Opioids are drugs prescribed for mild to severe pain relief and act on the nervous system. This group of drugs has created quite a stir due to the long-term use by millions of people across the nation resulting in misuse and dependence. This crisis has the potential of disrupting the entire economy of the nation, calling for the President’s … [Read more...]
Opioid Commission Meets with Insurance and Pharmaceutical Companies
The newly formed Commission on Combating Drug Addiction and the Opioid Crisis is expected to release its final report on the opioid epidemic – a report that will contain suggestions for further action – in about a week. Leading up to the release of the report, there have been a number of inquiries and actions that beg the question: what is the … [Read more...]
Big Pharma Regulations Might Be an Obstacle for Pending Lawsuits
More and more lawsuits are being filed against pharmaceutical companies for downplaying the addictive effects of opioid painkillers. However, some suggest that the regulatory environment surrounding Big Pharma might preclude success in these cases. This past Wednesday, Ohio joined the list of plaintiffs when the state filed a lawsuit against Purdue … [Read more...]
Op-Ed By Larry Golbom – Addiction: The FDA and OxyContin
This is an editorial written by Larry Golbom of Prescription Addiction Radio. All viewpoints are welcome here at US Recall News. If you would like to write an editorial response please use the comment section below or contact us with your proposal. FDA: Please Stop Oxycontin! By Larry Golbom: In February 2009, the FDA announced that they would … [Read more...]
OxyContin and the Opium Epidemic of the 21st Century
Beginning over two hundred years ago, the opium plant was credited with being implicated in destroying the Chinese dynasties that had ruled China for thousands of years prior to The Republic of China being created in 1912. With opium reaching China’s shores in increasing amounts, the Chinese Emperor, Ch'ien Chieh, has been attributed to the … [Read more...]
Recent Comments